HomeGreater Than Icon
GlaxoSmithkline Consumer Healthcare Ltd(Merged)Greater Than Icon
GlaxoSmithkline Consumer Healthcare Ltd(Merged) Financials
Company Logo

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Financial Statement

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Dec 2019
Revenue1274.90
Operating Expense886.78
Net Profit276.63
Net Profit Margin21.70
Earning Per Share65.77
EBIDTA386.61
Effective Tax Rate23.01

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
Total Revenue Annual4,782.01
Operating Expenses Annual3,641.04
Operating Profit Annual1,573.57
Interest Annual0.78
Depreciation60.35
Net Profit Annual982.80
Tax Annual529.49

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
Cash Flow at the Beginning614.10
Cash Flow from Operations671.07
Cash Flow from Investing-335.06
Cash Flow from Financing-376.80
Cash Flow at the End573.32

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
PBDIT Margin (%)32.91
PBIT Margin (%)31.64
PBT Margin (%)-8.93
Net PROFIT Margin (%)20.55
Return On Networth / Equity (%)25.93
Return On Networth /Employed (%)38.19
Return On Assets (%)24.87
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)1.21

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
Fixed Assets Annual467.21
Total Current Assets Annual5,267.42
Non Current Assets Annual800.67
Total Shareholders Funds Annual4,094.71
Total Assets Annual6,068.09

GlaxoSmithkline Consumer Healthcare Ltd(Merged) Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, GlaxoSmithkline Consumer Healthcare Ltd(Merged) has a market capitalization of 30,336.20 Cr. Value Research classifies it as a Large-Cap company.
Yes, GlaxoSmithkline Consumer Healthcare Ltd(Merged) is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , GlaxoSmithkline Consumer Healthcare Ltd(Merged) recorded a total revenue of approximately 4,782.01 Cr marking a significant milestone in the company's financial performance.
GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..
GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s current PE ratio is 30.87.
GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s ROCE averaged 32.9% from the FY ending March 2017 to 2019, with a median of 31.8%. It peaked at 36.4% in March 2019, reflecting strong capital efficiency over the period..
GlaxoSmithkline Consumer Healthcare Ltd(Merged)'s latest EBIT is Rs. 1,513.07 Cr, surpassing the average EBIT of Rs. 1,200.88 Cr over the 5 years..